In partnership with the vfa
What you’ll learn from this webinar
In this webinar, we explore how Germany’s new Medical Research Act will reshape the European clinical trial landscape. This groundbreaking reform is designed to streamline approvals, reduce bureaucracy, and accelerate trial execution – unlocking Germany’s full potential as a key hub for innovation, with lessons to be learned for global trial organizers.
Join experts from vfa, Boehringer Ingelheim, Sanofi, BMS and Clariness as we break down:
Speakers:
- Dr. Michael Busse, Head of Clinical Research at Boehringer Ingelheim (HQ in Germany)
- Dr. Katrin Roscher, Head Clinical Study Unit GSA at Sanofi (HQ in France)
- Dr. Susanne Busta, Head of Clinical Operations DACH at Bristol-Myers Squibb – BMS (HQ USA)
- Dr. Thorsten Ruppert, Senior Manager Research, Development and Innovation at the vfa (National association for German pharmaceuticals)
- Moritz Kloss, SVP Registry & Local Markets, Clariness